|
|
fertilization
|
GO:0009566 |
127 |
0.370
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.333
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.323
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.226
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.164
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.157
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.155
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.142
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.136
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.131
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.116
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.098
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.094
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.093
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.093
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.088
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.082
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.082
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.081
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.072
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.071
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.071
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.071
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.070
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.067
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.066
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.066
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.066
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.064
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.064
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.062
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.061
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.061
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.058
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.058
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.056
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.056
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.056
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.055
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.054
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.054
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.053
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.053
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.051
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.050
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.049
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.047
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.047
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.047
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.047
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.046
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.046
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.046
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.045
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.045
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.045
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.044
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.044
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.044
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.044
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.044
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.044
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.043
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.041
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.041
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.041
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.040
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.040
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.040
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.039
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.039
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.039
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.039
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.038
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.038
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.038
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.038
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.037
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.037
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.036
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.036
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.035
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.035
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.035
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.035
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.035
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.034
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.033
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.033
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.033
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.033
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.032
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.032
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.032
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.031
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.031
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.031
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.031
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.031
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.031
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.031
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.031
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.031
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.030
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.029
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.029
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.028
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.028
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.028
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.028
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.028
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.028
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.027
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.027
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.027
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.027
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.027
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.027
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.027
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.026
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.026
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.026
|
|
|
|
positive regulation of dopamine uptake involved in synaptic transmission
|
GO:0051586 |
2 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.026
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.025
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.025
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.025
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.025
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.025
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.025
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.024
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.024
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.024
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.024
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.024
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.024
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.023
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.023
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.023
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.023
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.023
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.023
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.023
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.023
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.023
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.022
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.022
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.022
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.022
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.021
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.021
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.021
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.021
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.021
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.021
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.020
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.020
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.020
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.020
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.020
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.020
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.020
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.020
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.020
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.020
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.019
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.019
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.019
|
|
|
|
synapsis
|
GO:0007129 |
34 |
0.019
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.019
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.019
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.019
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.019
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.019
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.019
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.019
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.019
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.019
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
|
positive regulation of retinal ganglion cell axon guidance
|
GO:1902336 |
2 |
0.018
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.018
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.018
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.018
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.018
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.018
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.018
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.018
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.018
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.018
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.018
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.018
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.017
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.017
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.017
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.017
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.017
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.017
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.017
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.017
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.017
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.017
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.017
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.016
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.016
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.016
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.016
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.016
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.016
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.016
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.016
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.016
|
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.016
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.016
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.016
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.016
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.016
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.016
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.016
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.015
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.015
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.015
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.015
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.015
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.015
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.015
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.015
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.015
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.015
|
|
|
|
cell cell signaling involved in mammary gland development
|
GO:0060764 |
2 |
0.015
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.015
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.015
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.015
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.014
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.014
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.014
|
|
|
|
memory
|
GO:0007613 |
58 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.014
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.014
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.014
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.014
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.014
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.014
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.014
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.014
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.014
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.014
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.014
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.013
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.013
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.013
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.013
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.013
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.013
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.013
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.013
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.013
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.013
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.013
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.013
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.013
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.013
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.013
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
18 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
male genitalia development
|
GO:0030539 |
20 |
0.013
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.013
|
|
|
|
regulation of complement activation classical pathway
|
GO:0030450 |
1 |
0.013
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.013
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.013
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.013
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.013
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.013
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.013
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.013
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.013
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.012
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.012
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.012
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.012
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.012
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.012
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.012
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.012
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.012
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.012
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.012
|
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.012
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.012
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.012
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.012
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.012
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.012
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.012
|
|
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.012
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.012
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.012
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.012
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.012
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.012
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.012
|
|
|
|
bile acid and bile salt transport
|
GO:0015721 |
5 |
0.012
|
|
|
|
regulation of dopamine uptake involved in synaptic transmission
|
GO:0051584 |
2 |
0.012
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.012
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.012
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.012
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.012
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.012
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.012
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.012
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.012
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.012
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.012
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.012
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.012
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.012
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.012
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.012
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.011
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.011
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.011
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.011
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.011
|
|